A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
about
Adverse effects of FK 506 overdosage after liver transplantationEffects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte culturesHepatic and intestinal transplantation at the University of Pittsburgh.Fluconazole therapy in transplant recipients receiving FK506.Hepatic Retransplantation--an analysis of risk factors associated with outcomeLong-term insulin requirement after liver transplantation with FK 506 in American veterans.FK506 in pediatric kidney transplantation--primary and rescue experienceRapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factorsRandomised trialomania? The multicentre liver transplant trials of tacrolimus.Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.Liver transplantation at the University of Pittsburgh, 1984 to 1990.Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.Tacrolimus in pediatric renal transplantation.The current status of hepatic transplantation at the University of PittsburghTacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntletThe superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disordersTacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trialRecent advances in hepatic transplantation at the University of PittsburghRenal transplantation at the University of Pittsburgh: the impact of FK506.The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantationA prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 yearsThe Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.FK506 in solid organ transplantation.A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantationA prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.Vasorelaxation and inhibition of the voltage-operated Ca2+ channels by FK506 in the porcine coronary artery.Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipientsCoronary Computed Tomography Angiography in Combination with Coronary Artery Calcium Scoring for the Preoperative Cardiac Evaluation of Liver Transplant Recipients.Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation.A prospective randomized trial of FK506-based immunosuppression after renal transplantation
P2860
Q28367999-796A258E-04BF-43CA-BB22-9CBA02432CE0Q34197184-1F2E802F-7263-4545-9B25-8C2D5AE4F59FQ34206468-F1002684-9A21-43DA-A359-6E7A150A324DQ34206947-9976F162-798F-4BE7-8CB2-1E8B94F4F980Q34207106-D606517E-0EF3-4985-9945-994EFC0B7905Q34248635-D85ABB84-D5C2-42E7-A634-675226F8EDB1Q34252083-7497CDCB-565D-4646-BA7B-592557846376Q34275901-2D0D8357-84B6-4A73-97D1-7EBBA6A741F1Q34289636-C6365A6D-B9FE-4820-86CC-403C33F429ADQ34292111-17FD0837-5A6A-4B3D-9937-A9A229761401Q34292315-998BE851-2461-4722-9776-B3D8530E420BQ34315230-AE6A1479-74CD-4786-B9F5-7186DA9EB50FQ34330427-F560AFFF-3806-4DAF-BB68-91E8629C6075Q34330449-5C8D91F4-D75E-4E57-AD02-EFD9DE7B884BQ34340969-B174E25C-F0BC-4713-843F-CEA9E6287FA0Q34346715-24D2797C-F396-4FF6-8192-F156910AF01FQ34470498-F4DB6B3C-E773-4AC9-9B61-E3FC63570A56Q34498312-90057A7B-4C1C-476F-BFC4-697FFB8C002EQ34546018-75039889-CE19-45FA-9978-95F8BCFC92C2Q34824999-DE3EDEC8-9AEF-48F6-9CF4-EDEA4EDF7D1DQ34965243-A024231D-F2EE-4FF8-A800-96836D364179Q36718780-078D236C-2801-4AC9-8274-B92ED3A5C6CAQ37181790-95FB84D1-4A32-45D5-BAFB-CD95C04B31AAQ40962151-22F3A50C-847C-4DC2-BAD6-4AC6047B7322Q41850534-FF2D3DB2-E8F7-4AFA-A10E-A3340EF90DEDQ41970570-67E4B45D-0EBD-4368-B14E-A82BD736874CQ41973154-26D3EA04-01A7-4A45-A9ED-8F6BB1F5E916Q41980963-8500F1A2-8703-4258-9CFA-B7CC58224840Q42071789-A03E2EC3-F4D5-458A-9972-DEA15FC0A126Q42177932-A1B1DF84-8446-4FCC-9714-80911D198A7BQ42239470-7283BDD1-23A3-4E45-A89A-2063CD8CD884Q42411557-D205FFA0-3082-4061-87F3-CCE6293F8638
P2860
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@ast
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@en
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@nl
type
label
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@ast
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@en
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@nl
prefLabel
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@ast
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@en
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@nl
P2093
P2860
P50
P1476
A randomized trial of primary ...... n with FK 506 vs cyclosporine.
@en
P2093
K Abu-Elmagd
M Alessiani
O Bronster
P2860
P304
P407
P577
1991-12-01T00:00:00Z